Next Science Limited (ASX: NXS) is a medical technology company headquartered in Sydney, Australia, with commercial operations in Florida, USA. Our journey began with a stark realization: Too many avoidable amputations were happening due to infected wounds. For our founder, this was unacceptable. Determined to make a difference, he set out on a mission to develop the science behind better healing. Today, that same passion drives us forward—redefining healing and transforming lives through science, innovation, and unwavering commitment. We deeply value the physician-patient connection and its life-changing impact through healthy healing. Our pursuit is to enhance patient outcomes, empower physicians, and drive healthcare innovation through education, research, and cutting-edge product development.
Looking for a particular Next Science employee's phone or email?
The Next Science annual revenue was $22.2 million in 2026.
I.v. Hall is the CEO and Managing Director of Next Science.
32 people are employed at Next Science.
The NAICS codes for Next Science are [54, 541, 5417, 54171, 541714].
The SIC codes for Next Science are [87, 873].